What BIOVOX does

BIOVOX GmbH is a Darmstadt-based materials company founded in 2021 that develops and sells Medical Grade bioplastic compounds to industrial buyers in the regulated healthcare sector. Its flagship MedEco portfolio comprises PLA-based, bio-PE-based, and high-transparency Perform grades formulated for injection molding, profile/tube/film extrusion, and extrusion blow molding, plus the Regiogradable® line of PBS-based compounds filled with regional organic residual materials (fruit peels, spent grains, wood waste, textiles) for hygiene, food-contact, and cosmetics applications. Each MedEco grade is supported by an ISO 13485-certified quality management system, ISO 10993 biocompatibility statements, regulatory information sheets, and LCA factsheets documenting up to 85% Cradle-to-Grave CO2 savings and freedom from PFAS, BPA, and phthalates. Materials are positioned as drop-in alternatives to PC/ABS at only a ~5–10% part-cost premium, frequently reaching price parity.

The company operates a pure B2B model, selling quote-priced granulate to OEMs, distributors, and packaging makers in MedTech, pharmaceutical, and laboratory sectors via direct enterprise sales, a Microsoft Bookings consultation funnel, trade fair presence (MedtecLIVE Stuttgart, Pharma Sustainability Days Geneva), and the co-founded BIOVOX Connect / Alliance for Sustainable Medical Technology network. Revenue mechanics are unit-volume sales of granulate under standard B2B General Terms and Conditions rather than subscriptions or licensing. Named enterprise relationships include Aesculap AG (B. Braun) via the B. Braun Accelerator Program, Röchling Medical (joint trocar redesign), and SoBiCo GmbH as a polymer supply partner, complemented by an unspecified life-science testimonial. Capital history consists of a mid-six-figure pre-seed round in April 2022 and a €2.2M seed round in September 2024 led by High-Tech Gründerfonds (HTGF), with no revenue disclosed to date.

Name

BIOVOX

Legal name

BIOVOX GmbH

Website

https://biovox.systems

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

BIOVOX GmbH (Darmstadt, Germany; founded 2021) develops and sells ISO 13485-certified Medical Grade bioplastic compounds (MedEco, Regiogradable®) to B2B OEMs, distributors, and packaging makers in the MedTech, pharmaceutical, laboratory, hygiene, and food-contact sectors.

Ownership category

akta.pro rank

Product category

Medical Grade Bioplastics

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Resin and Synthetic Rubber Manufacturing (32521)

SIC

Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)

akta.pro primary industry

Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT) (IMAEAOAA)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Biodegradable Packaging Materials (films, trays, foams) (IMAEAOAB), Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends) (IMANABAF)

Keywords

• Medical grade bioplastics
• Bioplastic compounds
• Medical device materials
• Pharmaceutical packaging plastics
• Sustainable bioplastics

Headquarters

HQ city

Darmstadt

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. B2B sales of Medical Grade bioplastic compounds (granulates/pellets): Sales of MedEco and Regiogradable bioplastic compounds (units of material/granulate) to distributors and OEMs in the MedTech, pharmaceutical, and laboratory equipment sectors. The job description specifies BIOVOX is exclusively B2B, with only a "moderate" cost increase of ~5–10% over PC/ABS-based compounds observed in projects, often achieving price parity. Revenue is driven by unit volumes of bioplastic material sold to industrial customers rather than subscriptions or licensing.
2. General Terms and Conditions (B2B) governing material sales: Sales are governed by BIOVOX General Terms and Conditions (B2B) and General Terms and Conditions of Purchase, indicating standard commercial material supply transactions rather than subscription-based delivery.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

Core offering

BIOVOX develops, produces, and sells Medical Grade bioplastic compounds (granulates) under the MedEco brand for use in medical technology, pharmaceutical, and laboratory applications. The portfolio includes PLA-based grades (ICB, IGH, XCB), bio-PE-based grades (IPI, XPI), high-transparency sterilizable Perform grades (ICH, XCI), and the Regiogradable® upcycled PBS-based compound line for hygiene, food-contact, and cosmetics. All products are ISO 13485 certified, ISO 10993 biocompatible, and VDI 2017 Medical Grade, sold B2B to OEMs, distributors, and packaging manufacturers.

Product overview

BIOVOX GmbH is a single-platform materials company that develops and supplies a portfolio of medical-grade bioplastic compounds under the "MedEco" brand (covering PLA-based grades such as MedEco ICB/IGH/XCB/XGB, bio-PE-based grades such as MedEco IPI/XPI, and the high-transparency sterilizable MedEco Perform ICH/XCI line) plus the upcycled, home-compostable "Regiogradable" PBS-based compound line for non-medical and consumer applications. These are complemented by a set of knowledge and consulting offerings: the open BioWiki knowledge base, the gated BE GREEN Compendium, the BIOVOX Connect network (co-founder of the Alliance for Sustainable Medical Technology), and material/design-for-sustainability consulting for medical device manufacturers. All products are sold B2B to OEMs, distributors, and packaging makers in medical technology, pharmaceutical, laboratory, hygiene, food, and cosmetics segments, backed by ISO 13485-certified quality management, ISO 10993 biocompatibility, and VDI 2017 Medical Grade quality.

Differentiator

Problem solved

Functional benefit

Brands

• BIOVOX MedEco: Medical-grade bioplastic compound family (e.g., MedEco ICB, IGH, IPI, XCB, XGB, Perform ICH/XCI) for medical technology, pharma, hygiene, and laboratory applications.
• BIOVOX Regiogradable
• BIOVOX Connect

Products and services

• MedEco Bioplastics (Medical Grade Bioplastic Compound Family)
• Regiogradable® Bioplastics Bio-based PBS (polybutylene succinate) compound filled with regional organic residual materials such as fruit peels, spent grains, wood waste, or textiles, turning waste streams into value. Home-compostable at 30°C, food-safe, vegan, microplastic-free, with no release of harmful substances or VOCs. Base material certified to DIN EN 13432. Available with various bio-based fillers and food-safe coloring options. Used in single-use hygiene products, food-contact products, and cosmetics.
• BIOVOX Connect Membership network for sustainable medical products and co-founder platform of the Alliance for Sustainable Medical Technology. Partners include BIOPRO Baden-Württemberg, Bayern Innovativ Gesundheit, Kompetenzzentrum Arbeitsforschung Komatra, and Forum MedTech Pharma. Members receive access to a member area with exclusive content including the Bioplastics Compendium, online sessions, and meetups covering topics such as sustainability as a change process, emerging green materials, and product development and design.
• Material Sustainability & Design-for-Sustainability Consulting Consulting and engineering service that supports medical device manufacturers in re-designing products for sustainability. Services include FEM simulation, flow analysis, mass reduction engineering, monomaterial design for recycling, and modular design for reassembly. Demonstrated in a joint case study with Röchling Medical achieving over 50% CO2 footprint reduction and 32% material savings in a trocar re-design. Aimed at manufacturers in the medical technology sector.

Quantifiable outcome

• Up to 85% CO2 reduction (Cradle-to-Grave) vs fossil plastics, and partly over 100% Cradle-to-Gate
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• Forum MedTech Pharma e.V.coreStrategic or Co-development Partner · 1 April 2024Co-signatory of the MoU launching the Alliance for Sustainable Medical Technology (April 2024 group photo featuring Prof. Dr. Ralf Kindervater (BIOPRO), Dr. Jörg Traub (Forum MedTech Pharma), Dr. Julian Lotz (BIOVOX Connect)).
• BIOPRO Baden-Württemberg GmbHflagshipStrategic or Co-development PartnerCo-founder alongside BIOVOX of the Alliance for Sustainable Medical Technology (Allianz für nachhaltige Medizintechnik). Jointly organises online sessions on sustainability topics for the healthcare industry; alliance MoU signed 24 May 2023 in Nuremberg; visible joint press presence in Medizin & Technik and BIOPRO news.
• Gesundheit bei Bayern InnovativcoreStrategic or Co-development PartnerAlliance partner in the Alliance for Sustainable Medical Technology. Contributes its health innovation network to co-organised online sessions and joint ecosystem activities aimed at sustainable medical technology.
• Kompetenzzentrum Arbeitsforschung KomatracoreStrategic or Co-development PartnerAlliance partner in the Alliance for Sustainable Medical Technology. Co-organises online sessions and joint stakeholder engagement in the healthcare industry on sustainability topics.
• B. Braun (Aesculap AG)coreStrategic or Co-development PartnerCollaboration within the B. Braun Accelerator Program, referenced as the foundation for ongoing cooperation; Dr. Jürgen Wegmann (Director Packaging Processing and R&D Processes, Aesculap AG) provided a public testimonial stating the collaboration with BIOVOX can help achieve B. Braun's sustainability goals.
• Röchling MedicalcoreStrategic or Co-development PartnerJoint best-practice re-design of a trocar (sterile single-use instrument for minimally invasive surgery) integrating Design-for-Sustainability principles and BIOVOX's bio-based PLA. The re-design achieved over 50% lower CO2 footprint and 32% material savings. Case study features Röchling Medical Senior Specialist R&D Erika Unjaev.
• Microsoft (Bookings)minorOthersMicrosoft Bookings is integrated into the BIOVOX website to offer a free, no-obligation online appointment booking function for consultation requests. Data Processing Addendum in place per privacy policy.
• MailPoet (Aut O’Mattic A8C Ireland Ltd.)Others

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• NatureWorks: World's largest PLA producer (Ingeo biopolymer), with grades targeted at medical devices, packaging, and consumer goods. Directly comparable to BIOVOX as a PLA-based bioplastic resin supplier pushing into healthcare applications.
• FKuR Kunststoff: German specialty compounder of bio-based and biodegradable plastics (Bio-Flex, Terralene, Ecovio-type compounds) sold to industrial converters. Mirrors BIOVOX's role as a curated bioplastic compounder with application-engineering support.
• Danimer Scientific: US-based producer of Nodax PHA biopolymers targeting packaging, foodservice, and specialty applications including potential medical use. Comparable as a bioplastic resin supplier positioning in regulated, sustainability-driven end markets.
• Novamont: Italian developer of Mater-Bi bioplastics (bio-based and compostable) for packaging, food-service, and specialty applications. Comparable to BIOVOX as a bioplastic compounder selling into regulated end markets with a sustainability story.
• TotalEnergies Corbion: Joint venture offering Luminy PLA bioplastics, including grades marketed for medical and packaging applications. Closely overlaps BIOVOX's MedEco PLA positioning and target end markets.

Broad incumbents

• Braskem: Brazilian petrochemical major producing I'm green bio-based polyethylene (sugarcane-derived) and increasingly exploring medical applications. Overlaps with BIOVOX's bio-PE MedEco grades and sustainability-driven MedTech/packaging customers, but at far larger scale.
• BASF: Global chemical major offering bioplastic compounds such as Ecovio (PLA/PBAT blends) for packaging and other applications. Competes with BIOVOX in packaging and increasingly in medical plastics as part of a much broader portfolio.
• Evonik: Large German specialty chemicals company with medical-grade polymers (e.g., RESOMER bioresorbables, VESTAKEEP, VESTAMID) and broader sustainable plastics portfolio. Overlaps with BIOVOX on medical-grade quality and regulatory dossier support, but at significantly greater scale.

Emerging players

• LEHVOSS Group: German specialty polymer distributor and compounder offering engineering and bio-based compounds, including grades for medical and industrial applications. Comparable to BIOVOX as a Europe-based, application-engineering-led bioplastic specialist.
• Kingfa Sci & Tech: Chinese manufacturer of modified and bio-based plastics with growing presence in medical, automotive, and packaging. Comparable to BIOVOX as a specialty bioplastic compounder targeting medical-grade and sustainability-led applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@biovox
• LinkedInlinkedin.com/company/biovox-systems
• Xx.com/BIOVOXmaterials

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOVOX